Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 24;11(9):1412.
doi: 10.3390/vaccines11091412.

Efficacy and Safety of Vaccinations in Geriatric Patients: A Literature Review

Affiliations
Review

Efficacy and Safety of Vaccinations in Geriatric Patients: A Literature Review

Tiziana Ciarambino et al. Vaccines (Basel). .

Abstract

With the progressive lengthening of the average age of the population, especially in some countries such as Italy, vaccination of the elderly is a fixed point on which most of the public health efforts are concentrating as epidemic infectious diseases, especially those of the winter, have a major impact on the progression of severe disease, hospitalization, and death. The protection of the elderly against acute infectious diseases should not only limit mortality but also have a positive impact on the fragility of these people in terms of less disability and fewer care needs. However, vaccination of the elderly population differs in efficacy and safety compared to that of other population categories since aging and the consequent loss of efficiency of the immune system lead to a reduction in the immunogenicity of vaccines without achieving a lasting antibody coverage. There are various strategies to avoid the failure of immunization by vaccines such as resorting to supplementary doses with adjuvant vaccines, increasing the dosage of the antigen used, or choosing to inoculate the serum relying on various routes of administration of the vaccine. Vaccination in the elderly is also an important factor in light of growing antibiotic resistance because it can indirectly contribute to combating antibiotic resistance, reducing theoretically the use of those agents. Furthermore, vaccination in old age reduces mortality from infectious diseases preventable with vaccines and reduces the same rate of resistance to antibiotics. Given the importance and complexity of the topic, in this review, we will deal with the main aspects of vaccination in the elderly and how it can influence mortality and healthcare costs, especially in those countries where population aging is more evident. Therefore, we conducted a systematic literature search in PubMed to identify all types of studies published up to 31 May 2023 that examined the association between vaccination and the elderly. Data extraction and quality assessment were conducted by two reviewers (PC and TC) who independently extracted the following data and assessed the quality of each study.

Keywords: efficacy; elderly; health problem; safety; vaccination.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Importance of vaccination in the elderly.
Figure 2
Figure 2
Resistance to vaccine response in the elderly.

Similar articles

Cited by

References

    1. McElhaney J.E. Influenza vaccine responses in older adults. Ageing Res. Rev. 2011;10:379–388. doi: 10.1016/j.arr.2010.10.008. - DOI - PMC - PubMed
    1. Goronzy J.J., Weyand C.M. Understanding immunosenescence to improve responses to vaccines. Nat. Immunol. 2013;14:428–436. doi: 10.1038/ni.2588. - DOI - PMC - PubMed
    1. Devi K.S., Anandasabapathy N. The origin of DCs and capacity for immunologic tolerance in central and peripheral tissues. Semin. Immunopathol. 2017;39:137–152. doi: 10.1007/s00281-016-0602-0. - DOI - PMC - PubMed
    1. Della Bella S., Bierti L., Presicce P., Arienti R., Valenti M., Saresella M., Vergani C., Villa M.L. Peripheral blood dendritic cells and monocytes are differently regulated in the elderly. Clin. Immunol. 2007;122:220–228. doi: 10.1016/j.clim.2006.09.012. - DOI - PubMed
    1. Aiello A., Ligotti M.E., Garnica M., Accardi G., Calabrò A., Pojero P., Arasanz H., Bocanegra A., Blanco E., Chocarro L., et al. How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells. Int. J. Mol. Sci. 2022;23:9880. doi: 10.3390/ijms23179880. - DOI - PMC - PubMed

LinkOut - more resources